Human T-cell leukemia virus |
ATL, leukemic cell infiltration, pulmonary fibrosis |
CT showed ground glass opacities, bronchiectasis, centrilobular nodules, septal thickening, honeycombing and crazy-paving, suggesting the presence of pulmonary fibrosis |
No mention |
Assessment:[4]; reversibility: None |
Human immunodeficiency virus |
Interstitial pneumonia, pulmonary fibrosis |
HRCT demonstrated areas of ground glass opacification, consolidation and honeycombing, with interstitial infiltrate as the histopathologic feature |
No mention |
Assessment:[10]; reversibility: None |
Cytomegalovirus |
Interstitial pneumonia, pulmonary fibrosis |
HRCT demonstrated bilateral mixed areas of ground-glass opacity, poorly-defined centrilobular small nodules, and consolidation |
No mention |
Assessment:[22]; reversibility: None |
Epstein–Barr virus |
Unspecific interstitial lung disease, pulmonary fibrosis |
The open-lung biopsy showed uncharacteristic focal interstitial peribronchial infiltration in the left lower lobe, with histiocytes and lymphocytes as well as interstitial fibrosis and increased collagen tissue |
Reversible: After 26 months, chest X-ray showed only slight interstitial markings |
Assessment:[29]; reversibility: [29] |
Influenza virus |
ARDS, DAD bronchoalveolar pneumonia, pulmonary fibrosis |
Histologic features included bronchoalveolar pneumonia, interstitial septal thickening, type II pneumonocyte hyperplasia, fibrosis and squamous metaplasia. HRCT demonstrated ground glass opacity and consolidation |
Reversible: The one month follow-up CT scans showed that the fibrosis resolved |
Assessment:[36, 37]; reversibility: [37] |
Avian influenza virus |
ARDS, lymphopenia, pulmonary fibrosis |
CT findings in H5N1 and H7N9 patients were ground-glass opacities and lobar consolidation |
Reversible: The 12th month follow-up CT of patient showed only minimal residual fibrous lines |
Assessment:[44, 46]; reversibility: [44] |
MERS-CoV |
ARDS, multi-lobar airspace disease, pulmonary fibrosis |
CT showed multi-lobar airspace disease, ground-glass opacities and pleural effusions |
No mention |
Assessment:[57]; reversibility: none |
SARS-CoV |
ARDS, DAD, pulmonary fibrosis |
The histopathological findings were extensive edema, hyaline membrane formation, alveolar collapse, and alveolar epithelial desquamation. CT showed ground-glass opacities and consolidation |
Reversible: HRCT scan showed improvement of pulmonary fibrosis in one month |
Assessment:[67, 68, 71]; reversibility: [69, 72] |
SARS-CoV-2 |
ARDS, DAD, pulmonary fibrosis |
Histopathological examination of the lung biopsy tissues revealed bilateral acute changes with DAD, reactive type II pneumocyte and macrophage hyperplasia, patchy inflammatory cellular infiltration and loose interstitial fibrosis |
Reversible: Thin-section chest CT showed that pulmonary fibrosis developed in COVID-19 patients could reverse in about a third of the patients 120 days after the onset |
Assessment:[88]; reversibility: [86] |